16
Participants
Start Date
February 14, 2019
Primary Completion Date
April 21, 2020
Study Completion Date
April 21, 2020
Renaparin
50 mL added at one occasion ex-vivo to machine perfusion solution to treat kidney at least 3 hours prior to transplantation
Placebo
50 mL added at one occasion ex-vivo to machine perfusion solution to treat kidney at least 3 hours prior to transplantation
Department of Transplantation Surgery, Karolinska University Hospital, Huddinge, Stockholm
Transplantationscentrum, Sahlgrenska University Hospital, Gothenburg
Department of Surgical Sciences, Section of Transplantation Surgery, Uppsala University Hospital, Uppsala
Lead Sponsor
Corline Biomedical AB
INDUSTRY